Skip to main content
. 2022 Dec 21;24(1):124. doi: 10.3390/ijms24010124

Table 1.

Typical mitochondrial myopathies that are generally multisystem disorders.

Myophathy Pathogenesis Inheritance Age Mitochondrial Target Main Symptoms Prognosis
Kearns-Sayre syndrome (KSS) single large-scale deletions of mtDNA generally, not inherited. (sporadic), rare case of mitochondrial, autosomal dominant, or autosomal recessive before the age of 20 Mainly cyt C oxidase progressive external ophthalmoplegia, and pigmentary retinopathy. cardiac conduction block, cerebrospinal fluid protein greater than 100 mg/dL, cerebellar ataxia, short stature, deafness, dementia, and endocrine abnormalities slowly progressive disorder. Prognosis related to level of organs involvment. arrythmias
Chronic progressive external ophthalmoplegia (CPEO) Deletion/mutation of mtDNA (i.e., tRNA at nucleotide 3243 in which there is an A to G), or nuclear genes: POLG, C10orf2, RRM2B, SLC25A4, POLG2, DGUOK, SPG7 sporadic, mitochondrial, autosomal dominant, or autosomal recessive Aroud 40s years defective function of oxidative phosphorylation Ptosis, Limited eye movements, and Hearing loss, Mild muscle weakness, dysphagia, cataracts prognosis depends on the associated features,
Leigh syndrome Different pathogenic mutations identified in over 85 genes nuclear or mtDNA mutations. Generally, infancy and childhhod Dysfunction of pyruvate dehydrogenase complex and oxidative phosphorylation Mainly developmental delay or psychomotor regression failure to thrive, weakness/hypertonia, ataxia, oculomotor palsy, seizures, lactic acidosis generally poor
Mitochondrial DNA depletion syndrome (MDS) Different mutations in the TK2,SUCLA2, SUCLG1, RRM2B, DGUOK, MPV17, POLG, C10orf2; TYMP genes Maternal and autosomal recessive newborns, infants, children, or adult different subunits of mitochondrial respiratory chain complexes Different clinical pictures: Myopathic; encephalomyopathic; hepatocerebral; neurogastrointestinal generally poor
Mitochondrial encephalomyopathy, lactic acidosis and stroke like episodes (MELAS) mtDNA: m.3243A > G, gene MT-TL (80% of cases) and m.3271T > C tRNA mutation (10%) maternally inherited childhood tRNA and NADH dehydrogenase stroke-like episode, hemiparesis, hemianopia, or cortical blindness. focal or generalized seizures, recurrent migraine, vomiting, short stature, hearing loss, and muscle weakness. poor
Myoclonus epilepsy with ragged red fibers (MERRF) A-to-G transition at nucleotide 8344 (m.8344A > G) of the MT-TK genetRNA (Lys) Spontaneous mutations, maternally inherited Childhood, adolescence or early adulthood oxidative phosphorylation myoclonus, epilepsy, ataxia, myopathy, dementia, optic atrophy, deafness, peripheral neuropathy, spasticity, cardiomyopathy with WPW syndrome. Generally poor. It can depend on age, severity of symptoms, organs involved.
Maternally inherited deafness and diabetes (MIDD) mutation in mtDNA gene MT-TL1, encoding tRNA for leucine, and in rare cases in MT-TE and MT-TK genes, encoding tRNAs for glutamic acid, and lysine, respectively. maternally inherited mean age of onset is 30–40 years defective function of oxidative phosphorylation Diabetes, deafness, Chorioretinal abnormality, Dyschezia, Macular dystrophy, Malabsorption, Cerebellar hypoplasia, arrhythmias, heart failure, ophthalmoplegia, Muscular weakness, prognosis for MIDD is better than that for MELAS
Mitochondrial neurogastrointestinal encephalomyopathy (MNGIE) Mutations of TYMP gene (nDNA) autosomal recessive range from 5–60 years of age defective function of oxidative phosphorylation gastrointestinal disorders (dysphagia, cramping, vomiting, diarrhea, gastroparesis intestinal pseudo-obstruction) related to abnormal bowel motility. Neurological symptoms includes chronic progressive ophthalmoplegia, sensorimotor peripheral neuropathy progressive degenerative disorder with a poor prognosis
Neuropathy, ataxia, and retinitis pigmentosa (NARP) More frequent: m.8993T > C/G subunit 6 of mt ATPase gene maternally inherited Childhood defective function of oxidative phosphorylation sensory neuropathy, muscle weakness; ataxia, retinitis pigmentosa, developmental delay, seizures, dementia, deafness, arrhythmias. poor prognosis